CSF2 and gastric cancer: Lin et al. recently found that increased levels of CXCL8 and colony stimulating factor 2 (CSF-2), which facilitates macrophage-driven CXCL8 secretion, indicated poor clinical outcome and tumor progression in gastric cancer patients.